Prolactin increases HO-1 expression and induces VEGF production in human macrophages

Journal of Cellular Biochemistry

Volumn 93, Issue 1, 2004, Pages 197-206

  Malaguarnera, Lucia ^a,b   Imbesi, R M ^a   Scuto, A ^a   D'Amico, F ^a   Licata, F ^a   Messina, A ^a   Sanfilippo, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b NONE   (Italy)

Author keywords

Angiogenesis; Heme oxygenase 1; Macrophages; Prolactin

Indexed keywords

HEME OXYGENASE 1; MESOPORPHYRIN TIN; PROLACTIN; STANNIC CHLORIDE; VASCULOTROPIN; ENZYME INHIBITOR; HEME OXYGENASE; HMOX1 PROTEIN, HUMAN; MEMBRANE PROTEIN; METALLOPORPHYRIN; SUPEROXIDE; TIN DERIVATIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CULTURE; CELL DIFFERENTIATION; DRUG ANTAGONISM; METABOLISM; MONOCYTE;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; MACROPHAGES; MEMBRANE PROTEINS; METALLOPORPHYRINS; MONOCYTES; PROLACTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDES; TIN COMPOUNDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 10444242177     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20167     Document Type: Article

References (39)

1. Abdel-Aziz MT, el-Asmar MF, el-Miligy D, Atta H, Shaker O, Ghattas MH, Hosni H, Kamal N. 2003. Retrovirus-mediated human heme oxygenase-1 (HO-1) gene transfer into rat endothelial cells: The effect of HO-1 inducers on the expression of cytokines. Int J Biochem Cell Biol 35:324-332.
2. Abraham NG, Lin JH, Dunn MW, Schwartzman ML. 1987. Presence of heme oxygenase and NADPH cytochrome P-450 (c) reductase inhuman corneal epithelium. Invest Ophthalmol Vis Sci 28:1464-1472.
3. Abraham NG, Drummond GS, Lutton JD, Kappas A. 1996. The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 6:129-168.
4. Abraham NG, Scapagnini G, Kappas A. 2003. Human heme oxygenase: Cell cycle-dependent expression and DNA microarray identification of multiple gene responses after transduction of endothelial cells. J Cell Biochem 90:1098-1111.
5. Bazan JF. 1989. A novel family of growth factor receptors: A common binding domain in the growth hormone, prolactin, erythropoietin, and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun 164:788-795.
6. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. 1996. Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639-669.
7. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, Soares MP. 2000. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192:1015-1026.
8. Clapp C, Lopez-Gomez FJ, Nava G, Corbacho A, Torner L, Macotela Y, Duenas Z, Ochoa XX, Noris G, Acosta E, Garay E, Martinezd LE. 1998. Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: Evidence for autocrine effects. J Endocrinol 158:137-144.
9. Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJA. 1990. A new cytokine receptor superfamily. Trends Biochem Sci 15:265-270.
10. Deramaudt BM, Braunstein S, Remy P, Abraham NG. 1998. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68:121-127.
11. Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M, Maeda HTI. 1999. Induction of heme oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 80:1945-1954.
12. Dvorak HF. 1996. Wound that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 17:122-137.
13. Fernandez-Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML, Adamkievicz J, Elsasser HP, Müller R, Havemann K. 2000. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65:287-300.
14. Ferrara N, Henzel WJ. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factorspecific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858.
15. Ferrara N, Clapp C, Weiner R. 1991. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896-900.
16. Fidler IJ, Ellis LM. 1994. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188.
17. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nat Med 1:27-31.
18. Gala RR, Shevach EM. 1993. Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 133:1617-1623.
19. Goodman AI, Choudhury M, da-Silva JL, Schwartzman ML, Abraham NG. 1997. Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med 214:54-61.
20. Goodman AI, Li Volti G, Abraham NG, Malaguarnera L. 2002. Role of heme oxygenase in angiogenesis and renal carcinoma. Heme oxygenase in biology and medicine. Kluwer Academic/Plenum Publishers. pp 459-467.
21. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, Dulak J. 2003. Heme oxygenase and angiogenic activity of endothelial cells: Stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5:155-162.
22. Kappas A, Simionatto CS, Drummond GS, Sassa S, Anderson KE. 1985. The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin. Proc Natl Acad Sci USA 82:896-900.
23. Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T. 1988. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 81:485-497.
24. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625-4629.
25. Malaguarnera L, Pilastro MR, Quan S, Ghattas MH, Yang L, Mezentsev AV, Kushida T, Abraham NG, Kappas A. 2002. Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human endothelial cells. Int J Mol Med 4:433-440.
26. McCoubrey WK Jr, Huang TJ, Maines MD. 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247:725-732.
27. Nagy JA, Brown LF, Senger DR, Lanir N, Van De Water L, Dvorak AM, Dvorak HF. 1988. Pathogenesis of tumor stroma generation: A critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948:305-326.
28. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onue H, Ito Y, Inamura T, Ikezaki K, Fukui M, Iwaki T, Kuwano M. 1999. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5:1107-1113.
29. Quan S, Yang L, Abraham NG, Kappas A. 2001. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc Natl Acad Sci USA 98:12203-12208.
30. Schmeisser A, Geruchs CD, Zang H, Eskafi S, Graffy C, Ludwig J, Strasse RH, Daniel WG. 2001. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel® under angiogenic conditions. Cardiovascular Res 49:671-680.
31. Shibahara S, Muller RM, Taguchi H. 1987. Transcriptional control of rat heme oxygenase by heat shock. J Biol Chem 262:12889-12892.
32. Shibahara S, Yoshizawa M, Suzuki H, Takeda K, Meguro K, Endo K. 1993. Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J Biochem 113:214-218.
33. Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner RI, Martial JA. 1999. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 96:1246-1251.
34. Sunderkötter C, Steinbrank K, Goebeler M, Bhardwaj R, Sorg C. 1994. Macrophages and angiogenesis. J Leukoc Biol 55:410-422.
35. Torisu-Itakura H, Furue M, Kuwano M, Ono M. 2000. Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. Jpn J Cancer Res 91:906-910.
36. Tsuji MH, Yanagawa T, Iwasa S, Tabuchi K, Onizawa K, Bannai S, Toyooka H, Yoshida HTI. 1999. Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Lett 138:53-59.
37. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA. 2000. Angiogenesis in pituitary adenomas-relationship to endocrine function, treatment, and outcome. J Endocrinol 165:475-481.
38. Wiesel P, Foster LC, Pellacani A, Layne MD, Hsieh CM, Huggins GS, Strauss P, Yet SF, Perrella MA. 2000. Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators. J Biol Chem 275:24840-24846.
39. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M. 1997. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17:4015-4023.